#Rue mermoz besancon full
#Rue mermoz besancon Pc

Users should refer to the original published version of the material for the full abstract. If you wish to link to this page, you can do so by referring to the URL address below this line. No warranty is given about the accuracy of the copy. Please bookmark this page (add it to your favorites). However, users may print, download, or email articles for individual use. Copyright of BMC Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.

#Rue mermoz besancon Pc

Conclusions This study suggests that FOLFOX second-line therapy offered interesting efficacy results with an acceptable toxicity profile in metastatic PC patients with a good PS. For patients PS 0-1 versus 2-3, median PFS was 3.0 versus 1.2 months (log rank, p = 0.002), and median OS was 5.9 versus 2.6 months (log rank, p = 0.001). In multivariate analysis, PS was the only independent prognostic factor. Median PFS and OS were 1.8 and 4.3 months, respectively. Achat vente appartement f3 3 pièces 2 chambres f3 secteur rue jean mermoz dans copropriété au calme, sans ascenseur. No objective response was observed, and disease control rate was 36%. Appartement en vente, Besançon, 25 - Balcon. At the end of follow-up, all patients had progressed and 25 had died. Grade 3 toxicity was observed in 33% of patients (no grade 4 toxicity). Results Among 46 patients who received second-line chemotherapy, 27 patients (male, 55% median age, 61 years performance status (PS) 0-1, 44%) were treated with FOLFOX after progression to first-line gemcitabine alone (n = 20) or FOLFIRI.3 alternating with gemcitabine (n = 7).

Progression-free survival (PFS) and overall survival (OS) were estimated from the start of second-line chemotherapy using the Kaplan-Meier method. Realtime driving directions to 17 Rue Jean Mermoz, 17 Rue Jean Mermoz, Besanon, based on live traffic updates and road conditions from Waze fellow.

Aller au contenu principal Organisez votre voyage. Methods In this prospective observational cohort study, we analysed all consecutive patients who received second-line chemotherapy with FOLFOX among 98 patients with metastatic PC included in the FIRGEM study. Billets de bus pas chers pour aller partout en France et en Europe - Informations sur les horaires & les arrêts à Besançon - Wi-fi & prises électriques. Frdric Prat, Gastroenterology Department, Cochin Hospital, 27, rue du Faubourg St Jacques, 75014 Paris, France. The present study assessed the efficacy and safety of FOLFOX after failure of the first-line therapy used in the FIRGEM study. However, other therapeutics strategy has developed in first-line therapy, as the FIRGEM phase II study that evaluated gemcitabine alone versus FOLFIRI.3 alternating with gemcitabine every two months.

Abstract: Background FOLFOX second-line treatment seems to be a validated option for patients with pancreatic cancer (PC) progressing after gemcitabine chemotherapy.